How SCFAs modulate cardiometabolic disease risk by interacting with an individual’s adiposity parameters and diet.
Kuros Biosciences Expands into Extremities Markets – Biotech Investments
Kuros Biosciences AG / Key word(s): Miscellaneous/Personnel Kuros Biosciences Expands into Extremities Markets 19.11.2024 / 07:00 CET/CEST Commercial Highlights Appointment of Jantzen Cole as Vice